Notably, its documented mechanism, antagonizing NF-κB and MAPK-mediated pro-inflammatory cascades, could be conceptually aligned with the IL1R1-driven pathology implicated in our study of diabetes-associated IDD (42). Here, IL1R1 is linked to diabetes mellitus.